CORRECTING AND REPLACING -- MannKind Corporation t

VALENCIA, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by MannKind Corporation (Nasdaq: MNKD ) (TASE: MNKD ), please note that in the first paragraph the date of the presentation should be Thursday, January 12, 2017, not today as previously stated. The corrected release follows:

MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference

MannKind Corporation (Nasdaq: MNKD ) (TASE: MNKD ), focused on the discovery and development of therapeutic products for diabetes, will present on Thursday, January 12, 2017 at the 35 ^th Annual J.P. Morgan Healthcare Conference at 10:00 AM (PST) at the Westin St. Francis Hotel in San Francisco, California. 

Presenting from the Company will be its Chief Executive Officer, Matthew J. Pfeffer.    

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com .

About MannKind Corporation MannKind Corporation (Nasdaq: MNKD ) (TASE: MNKD ) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes.  MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Company Contact: Rose Alinaya SVP Finance 661-775-5300 ralinaya@mannkindcorp.com